Evidence map›Paper›PMID 27867547›Full record

ArticleJournal of thoracic disease2016

Clinicopathological features and prognosis of patients <45 years old with esophageal adenocarcinoma comparing to other age groups.

Su Yang, Haibo Li, Chunyi Jia, Xiao Ma, Wei Guo, Hecheng Li

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis.World journal of gastrointestinal oncology · 2021
    Article
  6. Is the age of diagnosis of esophageal adenocarcinoma getting younger? Analysis at a tertiary care center.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Su YangDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Haibo LiSchool of Public Health, Wannan Medical College, Wuhu 241002, China.
Chunyi JiaThe 2nd Department of Thoracic Surgery, Jilin Province Cancer Hospital, Changchun 130012, China.
Xiao MaDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Wei GuoDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Hecheng LiDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo analyze the clinicopathological features and prognosis of younger patients with esophageal adenocarcinoma (EAC).

methodsA total of 2,601 patients diagnosed with EAC between 1988 and 2011 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. All patients underwent primary tumor resection and regional lymphadenectomy without preoperative radiotherapy. The patients were into four age groups (<45, 45-59, 60-74, ≥75), with 94, 813, 1,272 and 422 patients in each group respectively.

resultsPatients in the age <45 group were more likely to have lymph node (LN) metastasis (P=0.002), postoperative radiotherapy (P<0.001) and advanced T and N stage (P=0.003, 0.014) compared to the other three groups. We then conducted two Cox proportional hazards model adjusted for the sex, race, number of LNs examined, histological grade, postoperative radiation. The hazard ratio (HR) was higher in patients <45 y and the survival rate were paradoxically lower compared to the patients between 45-60 years old (P=0.046, 0.039).

conclusionsThe patients <45 y had the most aggressive clinicopathological features of EAC and poorer survival rate after radical esophagectomy.

Indexed as

Esophageal adenocarcinoma (EAC)prognosisthe Surveillance, Epidemiology, and End Results (SEER)young patients

Identifiers

PMID27867547
PMCPMC5107463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.